Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Renin Angiotensin System Blockade on CD95 and ADMA Levels in Type-2 Diabetic Patients With Proteinuria

NCT00893425 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.

NCT NCT00893425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00893425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Renin Angiotensin System Blockade on CD95 and ADMA Levels in Type-2 Diabetic Patients With Proteinuria
Lead sponsor
Gulhane School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
April 30, 2009
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, diabetic nephropathy, proteinuria